Global Filgrastim Biosimilars Market Report 2020: Due to COVID-19, the Market is Expected to Decline from $511.15 Million in 2019 to $445.04 Million in 2020

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice